期刊文献+

加味参芪地黄汤在晚期前列腺癌最大限度雄激素阻断治疗中的应用 被引量:18

Application of Modified Shenqi Dihuang Decoction in Maximum Androgen Blockade Treatment for Advanced Prostate Cancer
下载PDF
导出
摘要 目的观察加味参芪地黄汤在晚期前列腺癌最大限度雄激素阻断治疗中应用的临床疗效。方法将64例接受最大限度雄激素阻断治疗的晚期前列腺癌患者随机分为治疗组和对照组各32例,治疗组去势后服用比卡鲁胺胶囊和加味参芪地黄汤,对照组去势后单纯服用比卡鲁胺胶囊,治疗6个月。治疗前后检测血清前列腺特异性抗原(TPSA)、游离前列腺特异性抗原(FPSA)及睾酮(T),采用前列腺癌中医证候问卷对中医症状进行评分。结果 2组治疗后PSA、FPSA、T均显著下降(P>0.05)。治疗后治疗组尿频尿不畅、食欲不振、神疲乏力、腰酸背痛、体质量减轻、自我评价得分评分降低(P<0.05),对照组尿频尿不畅、腰酸背痛、体质量减轻评分降低(P<0.05)。2组治疗后比较,尿频尿不畅、食欲不振、神疲乏力、腰酸背痛、体质量减轻、自我评价得分评分差异有统计学意义(P<0.05)。结论加味参芪地黄汤在晚期前列腺癌最大限度雄激素阻断治疗中可以有效提高患者的生存质量,改善临床症状。 Objective To observe the clinical efficacy of modified Shenqi Dihuang Decoction in maximum androgen blockade treatment for advanced prostate cancer. Methods Totally 64 cases of patients accepting maximum androgen blockade treatment for advanced prostate cancer were randomized divided into control group and treatment group, 32 cases for each group. The treatment group was treated by modified Shenqi Dihuang Decoction combined with Bicalutamide capsule, and control group was only treated by Bicalutamide capsule for six months. Serum PSA, FPSA and T before and after treatment were detected, and TCM syndrome scores were observed through TCM syndrome questionnaire for prostate cancer. Results PSA, FPSA and T were reduced in both groups(P >0.05). After treatment, the scores of urinary frequency and dribble urination, poor appetite, lack of mental weariness, body aches, weight loss, and overall self-evaluation in the treatment group were decreased(P <0.05), and the scores of urinary frequency and dribble urination, body aches, and weight loss were decreased in the control group(P <0.05). There was a significant difference in the urinary frequency and dribble urination, poor appetite, lack of mental weariness, body aches, weight loss, and overall self-evaluation score between the two groups(P <0.05). Conclusion Modified Shenqi Dihuang Decoction can effectively promote the life quality of patients with advanced prostate cancer in the maximum androgen blockade treatment and improve clinical symptoms.
出处 《中国中医药信息杂志》 CAS CSCD 2015年第12期26-29,共4页 Chinese Journal of Information on Traditional Chinese Medicine
关键词 加味参芪地黄汤 比卡鲁胺胶囊 晚期前列腺癌 最大限度雄激素阻断治疗 modified Shenqi Dihuang Decoction Bicalutamide advanced prostate cancer maximum androgen blockade treatment
  • 相关文献

参考文献7

  • 1Siegel R, Naishadham D, Jemal A. Cancer statistics,2013[J].CA:A Cancer Journal for Clinicians,2013,63:11-30.
  • 2Center MM, Jemal A, Lortet-Tieulent J, et al. Internationalvariation in prostate cancer incidence and mortality rates[J].European Urology,2012,61:1079-1092.
  • 3Prostate Cancer Trialists Collaborative Group. Maximum androgenblocked in advanced prostate cancer:an overview of the randomizedtrials[J]. Lancet,2000,355(10):1491.
  • 4NCCN Clinical Practice Guidelines in Oncology:Prostate Cancer.Version 1.2005.[EB/OL].[2010-02-01].http://www.nccn.org/.
  • 5陈磊,郁超.前列腺癌EORTCQLQ-C30+PR25问卷在中医药临床的运用与改良[C].上海:上海市中医泌尿男科年会优秀论文汇编,2009:23-25.
  • 6Hellerstedt BA, Pienta KJ. The truth is out there:an overallperspective on androgen deprivation[J]. Urol Oncol,2003,21(4):272-281.
  • 7古炽明,陈志强,王树声,汤桂兴.中医扶正抑瘤法治疗晚期前列腺癌回顾性分析[J].新中医,2011,43(12):79-81. 被引量:14

二级参考文献10

共引文献14

同被引文献210

引证文献18

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部